HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute hemodynamic response to intravenous enoximone: an animal study and preliminary report in infants after cardiac surgery.

Abstract
In light of previous studies in adults, we considered that enoximone could be useful in treating children with therapy-resistant cardiovascular insufficiency. Prior to clinical administration, we investigated the cardiovascular properties of enoximone in anesthetized and ventilated piglets characterized by small stroke volume and high heart rate. Enoximone was administered intravenously in increasing doses (0.25, 0.5, and 1 mg/kg). The animals were monitored with heart rate, systemic and pulmonary arterial pressures, and continuous electromagnetic flow. Enoximone induced a dose-dependent flow increase, whereby heart rate and systemic arterial pressure changed only slightly. With regard to persistent pulmonary hypertension in newborns, enoximone was also used in piglets to investigate the effects on endotoxin-induced, dopamine-resistant pulmonary hypertension. Enoximone (1 mg/kg i.v.) was given immediately after E. coli endotoxin (1.5 micrograms/kg i.v.) and inhibited the endotoxin-induced, eicosanoid-mediated pulmonary hypertension, whereas during infusion of dopamine (2 mg/kg/h), no drop in systemic blood pressure could be observed. In the clinical study, six infants with post-cardiac surgery low output syndrome despite maximal catecholamine inotropic support were given enoximone (i.v. bolus of 0.2, 0.5, or 1 mg/kg followed by continuous infusion of 7.5-10 micrograms/kg/min). Continuously measured mixed-venous oxygen saturation increased in a dose-related manner. Cardiac output increased significantly by 28%, accompanied by a decrease of arteriovenous oxygen content difference and O2 utilization ratio. The preliminary results show that intravenous enoximone produces acute useful hemodynamic effects in infants, in particular allowing a weaning of vasoactive amines.
AuthorsD Schranz, R Huth, M Dahm, S Iversen, E Hein, H Stopfkuchen, B K Jüngst
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 14 Suppl 1 Pg. S62-8 ( 1989) ISSN: 0160-2446 [Print] United States
PMID2480488 (Publication Type: Journal Article)
Chemical References
  • Cardiotonic Agents
  • Imidazoles
  • Enoximone
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Cardiac Surgical Procedures
  • Cardiotonic Agents (administration & dosage, adverse effects, pharmacology)
  • Enoximone
  • Female
  • Heart Rate (drug effects)
  • Hemodynamics (drug effects)
  • Humans
  • Imidazoles (administration & dosage, adverse effects, pharmacology)
  • Infant
  • Injections, Intravenous
  • Male
  • Pulmonary Circulation (drug effects)
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: